Triumph Capital Management’s Hims & Hers Health HIMS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIMS
DE
Triumph Capital Management's HIMS Position: Q1 2026 in Review
Triumph Capital Management sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 45 shares — an estimated $1.46K sold.
Triumph Capital Management first reported a position in HIMS in Q2 2023 and held it in 2 quarters. The position peaked at $232K in Q2 2023. 436 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.
- Triumph Capital Management reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
- Triumph Capital Management sold 45 Hims & Hers Health shares in Q1 2026, an estimated $1.46K.
- Triumph Capital Management first reported a position in Hims & Hers Health in Q2 2023 and held it in 2 quarters.
- Triumph Capital Management's Hims & Hers Health position peaked at $232K in Q2 2023.
- 436 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.
Based on Triumph Capital Management's 13F filing for Q1 2026, filed 13 May 2026.